Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Clinical trial NCT06931145 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06931145
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2027-04-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.